243 related articles for article (PubMed ID: 28680095)
21. High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.
Kitaura K; Fujii Y; Hayasaka D; Matsutani T; Shirai K; Nagata N; Lim CK; Suzuki S; Takasaki T; Suzuki R; Kurane I
J Immunol; 2011 Oct; 187(8):3919-30. PubMed ID: 21908734
[TBL] [Abstract][Full Text] [Related]
22. Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus.
Kumar M; Roe K; Nerurkar PV; Orillo B; Thompson KS; Verma S; Nerurkar VR
J Neuroinflammation; 2014 Apr; 11():80. PubMed ID: 24750819
[TBL] [Abstract][Full Text] [Related]
23. Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain.
Kumar M; Roe K; O'Connell M; Nerurkar VR
J Neuroinflammation; 2015 Sep; 12():178. PubMed ID: 26392176
[TBL] [Abstract][Full Text] [Related]
24. Examination of West Nile Virus Neuroinvasion and Neuropathogenesis in the Central Nervous System of a Murine Model.
Sultana H
Methods Mol Biol; 2016; 1435():83-101. PubMed ID: 27188552
[TBL] [Abstract][Full Text] [Related]
25. Techniques for Experimental Infection of Mosquitoes with West Nile Virus.
Liu Y; Cheng G
Methods Mol Biol; 2016; 1435():151-63. PubMed ID: 27188557
[TBL] [Abstract][Full Text] [Related]
26. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
27. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.
Arjona A; Foellmer HG; Town T; Leng L; McDonald C; Wang T; Wong SJ; Montgomery RR; Fikrig E; Bucala R
J Clin Invest; 2007 Oct; 117(10):3059-66. PubMed ID: 17909632
[TBL] [Abstract][Full Text] [Related]
28. Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice.
Hunsperger EA; Roehrig JT
J Neurovirol; 2009 May; 15(3):211-8. PubMed ID: 19444694
[TBL] [Abstract][Full Text] [Related]
29. West Nile Virus Spreads Transsynaptically within the Pathways of Motor Control: Anatomical and Ultrastructural Mapping of Neuronal Virus Infection in the Primate Central Nervous System.
Maximova OA; Bernbaum JG; Pletnev AG
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004980. PubMed ID: 27617450
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
Nelson J; Roe K; Orillo B; Shi PY; Verma S
Antiviral Res; 2015 Oct; 122():39-45. PubMed ID: 26225754
[TBL] [Abstract][Full Text] [Related]
31. Minocycline Has Anti-inflammatory Effects and Reduces Cytotoxicity in an
Quick ED; Seitz S; Clarke P; Tyler KL
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878079
[TBL] [Abstract][Full Text] [Related]
32. Amino acid 159 of the envelope protein affects viral replication and T-cell infiltration by West Nile virus in intracranial infection.
Kobayashi S; Kaneko C; Kawakami R; Hasebe R; Sawa H; Yoshii K; Kariwa H
Sci Rep; 2020 Apr; 10(1):7168. PubMed ID: 32346055
[TBL] [Abstract][Full Text] [Related]
33. Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.
Zukor K; Wang H; Hurst BL; Siddharthan V; Van Wettere A; Pilowsky PM; Morrey JD
J Neurovirol; 2017 Apr; 23(2):186-204. PubMed ID: 27761801
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.
Wang P; Dai J; Bai F; Kong KF; Wong SJ; Montgomery RR; Madri JA; Fikrig E
J Virol; 2008 Sep; 82(18):8978-85. PubMed ID: 18632868
[TBL] [Abstract][Full Text] [Related]
35. Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.
Hunsperger EA; Roehrig JT
J Neurovirol; 2006 Apr; 12(2):129-39. PubMed ID: 16798674
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.
Glass WG; Lim JK; Cholera R; Pletnev AG; Gao JL; Murphy PM
J Exp Med; 2005 Oct; 202(8):1087-98. PubMed ID: 16230476
[TBL] [Abstract][Full Text] [Related]
37. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier.
Verma S; Lo Y; Chapagain M; Lum S; Kumar M; Gurjav U; Luo H; Nakatsuka A; Nerurkar VR
Virology; 2009 Mar; 385(2):425-33. PubMed ID: 19135695
[TBL] [Abstract][Full Text] [Related]
38. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.
Samuel MA; Whitby K; Keller BC; Marri A; Barchet W; Williams BR; Silverman RH; Gale M; Diamond MS
J Virol; 2006 Jul; 80(14):7009-19. PubMed ID: 16809306
[TBL] [Abstract][Full Text] [Related]
39. Depletion of Microglia in an
Stonedahl S; Leser JS; Clarke P; Tyler KL
Microbiol Spectr; 2022 Apr; 10(2):e0068522. PubMed ID: 35412380
[TBL] [Abstract][Full Text] [Related]
40. The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response.
Daffis S; Lazear HM; Liu WJ; Audsley M; Engle M; Khromykh AA; Diamond MS
J Virol; 2011 Jun; 85(11):5664-8. PubMed ID: 21411525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
